Knight Therapeutics Inc. (GUD.TO) Financials

GUD.TO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.1 billion 299.3 million
Dec. 31, 2025 1.0 billion 279.0 million
Sept. 30, 2025 1.0 billion 281.8 million
June 30, 2025 1.0 billion 274.9 million

GUD.TO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 37.1 million ?
Dec. 31, 2025 33.8 million 2.9 million
Sept. 30, 2025 10.1 million ?
June 30, 2025 -4.9 million 2.5 million

GUD.TO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 13.2 million
Dec. 31, 2025 8.9 million
Sept. 30, 2025 -3.8 million
June 30, 2025 -12.6 million

GUD.TO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 127.3 million 40.7 million 7.4 million
Dec. 31, 2025 95.3 million 51.2 million 6.6 million
Sept. 30, 2025 95.6 million 78.7 million 6.0 million
June 30, 2025 116.4 million 78.8 million 7.1 million

GUD.TO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 98.9 million
Dec. 31, 2025 99.2 million
Sept. 30, 2025 99.7 million
June 30, 2025 99.6 million

GUD.TO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3.3 million 9.4 million 34.4 million -
Dec. 31, 2025 505000 9.2 million 35.5 million -
Sept. 30, 2025 410000 8.7 million 31.0 million -
June 30, 2025 25.1 million 6.3 million 31.5 million 15.7 million

GUD.TO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 148.4 million 94.0 million
Dec. 31, 2025 133.1 million 82.2 million
Sept. 30, 2025 121.5 million 81.2 million
June 30, 2025 107.4 million 62.5 million

GUD.TO

Price: CA$8.61

52 week price:
5.42
8.87

Earnings Per Share: 0.06 CAD

P/E Ratio: 144.33

Exchange: TOR

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 850.9 million

Links: